Randomized, double-blinded, placebo-controlled trial to determine the safety and efficacy of CYR-064.

Investigator: Masayoshi Takashima, MD

Study Coordinator: Tariq Syed

Status: Enrolling

ClinicalTrials.gov Number: NCT06019000

Phone: 346.238.6466

Protocol Number: PRO00035015

Description

The purpose of this study is to determine the safety and effectiveness of CYR-064 in a randomized, double-blinded, placebo-controlled trial to determine the safety and efficacy of CYR064. The study will take approximately 32 weeks which will include a 4-week screening period to evaluate if participants are right for the Study, followed by a 24-week Treatment Period, and a 1 week follow up after participants have completed the Study. About 150 subjects will participate in this study in about 25 research sites in the United States.
More to Explore
Search Clinical Trials
Join a Clinical Trial
Clinical Research Support Services for Investigators
Weill Cornell Medical College Clinical Trials